{
 "categories": [
  "healthcare",
  "clinical",
  "public-sector"
 ],
 "deployment": "hybrid",
 "evidence": [
  {
   "date": "2026-09-09",
   "fact": "homepage",
   "note": "Omda presents the medical-oncology medication-management solution, naming the browser-based Cytodose web application, ELAS, and Omda Oncology modules.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "vendor",
   "note": "The product page identifies Omda as the vendor, with the Medication Management contact based at headquarters in Oslo.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "name",
   "note": "The 2024-09-25 Omda release names the product Omda Cytodose and states Helse S\u00f8r-\u00d8st selected it. The 90 percent Norwegian coverage figure is vendor-declared.",
   "source": "https://omda.com/south-eastern-norway-regional-health-authority-selects-omdas-medication-management-solution-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "deployment",
   "note": "The page states local installation at the customer's premises and also describes a browser-based Cytodose application, a web pharmacy module, and browser ELAS.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "platforms[0]",
   "note": "Omda describes encrypted traffic in the browser-based Cytodose web application and ELAS accessible via a browser interface.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "license",
   "note": "Access is offered through demo and sales contact. The page does not publish a public price list or self-serve plan.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.api.exists",
   "note": "Omda states interoperability with electronic patient records, laboratory systems, and pharmacy logistics, and that production orders can be integrated with compounding robots.",
   "source": "https://omda.com/south-eastern-norway-regional-health-authority-selects-omdas-medication-management-solution-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.api.coverage",
   "note": "The product page names integrations with external pharmacy systems, cytostatic compounding robots, SIL/FEST, and context sync, but does not publish endpoints, auth, or a protocol catalog. Coverage stays unknown.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.data_access.import[0]",
   "note": "Omda Application Specialist Rasmus B\u00e4ckstr\u00f6m states that protocols from the Swedish repository can be downloaded and imported into Cytodose via XML.",
   "source": "https://omda.com/oncology-and-beyond-broadening-the-market-for-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.rpa.ui_stack[0]",
   "note": "Cytodose and ELAS are described as browser applications. No UI probe was run.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.rpa.notes",
   "note": "Omda states GDPR audit logging, encrypted browser traffic, local on-premises installation, SITHS smart-card user access, and Class I CE marking under EU MDR.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.mcp.first_party",
   "note": "Opened Omda oncology product pages do not declare a first-party MCP server or declare its absence. Ownership stays unknown.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.agent_docs.llms_txt",
   "note": "Opened https://omda.com/llms.txt and received HTTP 404.",
   "source": "https://omda.com/llms.txt",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "modalities.computer_use.viability",
   "note": "No computer-use probe artifact was produced. Viability stays unknown.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.best_path",
   "note": "Named interoperability is the only evidenced machine path. No public MCP, CLI, or connector catalog was opened for this product.",
   "source": "https://omda.com/south-eastern-norway-regional-health-authority-selects-omdas-medication-management-solution-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.scores.api",
   "note": "Vendor pages name interoperability and XML protocol import but no public contract, auth, or endpoints. That is a narrow, gated, incomplete path. Score 3.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.scores.api",
   "note": "Opened https://omda.com/api and received HTTP 404.",
   "source": "https://omda.com/api",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.scores.api",
   "note": "Opened https://omda.com/developer and received HTTP 404.",
   "source": "https://omda.com/developer",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.scores.api",
   "note": "Opened the former marketing path and received HTTP 404.",
   "source": "https://omda.com/solutions/medication-management/omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "verdict.scores.overall",
   "note": "Overall equals the highest assessed path score (API 3).",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "freshness.watch[0].url",
   "note": "Opened as the current Omda medical-oncology product page, including Cytodose web application, ELAS, and named integrations.",
   "source": "https://omda.com/solutions/medical-oncology/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "freshness.watch[1].url",
   "note": "Opened as the current HS\u00d8 selection release for Omda Cytodose.",
   "source": "https://omda.com/south-eastern-norway-regional-health-authority-selects-omdas-medication-management-solution-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "freshness.watch[2].url",
   "note": "Opened as the vendor article that states XML import of Swedish treatment protocols into Cytodose.",
   "source": "https://omda.com/oncology-and-beyond-broadening-the-market-for-omda-cytodose/",
   "tier": "declared"
  },
  {
   "date": "2026-09-09",
   "fact": "freshness.watch[3].url",
   "note": "Opened the former-brand URL. The page now titles Omda Cytodose and repeats EPR, lab, robot, billing, and inventory interoperability.",
   "source": "https://omda.com/region-vastmanland-in-sweden-selects-csam-cytodose/",
   "tier": "declared"
  }
 ],
 "freshness": {
  "last_verified": "2026-09-09",
  "volatility": "medium",
  "watch": [
   {
    "type": "docs",
    "url": "https://omda.com/solutions/medical-oncology/"
   },
   {
    "type": "docs",
    "url": "https://omda.com/south-eastern-norway-regional-health-authority-selects-omdas-medication-management-solution-omda-cytodose/"
   },
   {
    "type": "docs",
    "url": "https://omda.com/oncology-and-beyond-broadening-the-market-for-omda-cytodose/"
   },
   {
    "type": "docs",
    "url": "https://omda.com/region-vastmanland-in-sweden-selects-csam-cytodose/"
   }
  ]
 },
 "homepage": "https://omda.com/solutions/medical-oncology/",
 "id": "omda-cytodose",
 "license": "commercial",
 "modalities": {
  "agent_docs": {
   "llms_txt": false
  },
  "api": {
   "auth": [],
   "coverage": "unknown",
   "docs": null,
   "exists": true,
   "kinds": []
  },
  "cli": {
   "exists": "unknown"
  },
  "computer_use": {
   "issues": [],
   "viability": "unknown"
  },
  "data_access": {
   "export": [],
   "import": [
    "xml"
   ]
  },
  "extensibility": {
   "scripting": [],
   "webhooks": "unknown"
  },
  "integrations": {
   "make": "unknown",
   "n8n": "unknown",
   "power_automate": "unknown",
   "zapier": "unknown"
  },
  "mcp": {
   "first_party": "unknown",
   "third_party": [],
   "verdict": "unknown"
  },
  "rpa": {
   "drivability": "unknown",
   "notes": "No repeatable UI probe was run. Omda describes a browser-based Cytodose application, a web pharmacy module, and browser ELAS nurse administration, plus local on-premises installation for sensitive data. Public pages name hospital interoperability and XML protocol import, not a self-serve API catalog. Oncology medication data are safety-critical and GDPR-regulated; browser control is not a substitute for a scoped hospital interface.\n",
   "ui_stack": [
    "web-dom"
   ],
   "vendor_support": []
  },
  "sdk": {
   "exists": "unknown",
   "languages": [],
   "official": "unknown"
  }
 },
 "name": "Omda Cytodose",
 "platforms": [
  "web"
 ],
 "related": {
  "alternatives": [
   "dips",
   "epic-ehr",
   "e-resept"
  ],
  "our_products": []
 },
 "schema_version": 1,
 "score_version": 1,
 "status": "active",
 "vendor": "Omda",
 "verdict": {
  "best_path": "api",
  "scores": {
   "api": 3,
   "cli": null,
   "computer_use": null,
   "integrations": null,
   "mcp": null,
   "overall": 3,
   "rpa": null
  },
  "summary": "The best evidenced machine path into Omda Cytodose is vendor-named hospital interoperability, not a published API contract. Omda presents Cytodose as the oncology medication-management product in the Omda Oncology family, covering prescribing, web pharmacy compounding, and ELAS nurse administration. Product pages state interoperability with electronic patient records, laboratory systems, pharmacy logistics, compounding robots, pharmacy billing, inventory, and national medicine repositories (SIL/FEST). A 2022 vendor article states that Swedish treatment protocols can be imported into Cytodose via XML. Public pages do not publish protocol, authentication methods, endpoints, or a developer catalog. omda.com/api, omda.com/developer, and omda.com/solutions/medication-management/omda-cytodose/ returned 404 on 2026-09-09. First-party MCP ownership is not established. Computer-use viability is unassessed. CSAM Cytodose is a former brand; opened pages now use Omda. Omda Wellme, DIPS, Epic, and e-resept are outside this record.\n"
 }
}